Dale Gieringer, Ph.D.
Dale Gieringer has been the state coordinator of California NORML (National Organization for the Reform of Marijuana Laws) since 1987. He is also Vice-Chairman of the national NORML board of directors, director of the California Drug Policy Forum (DPFCA) and treasurer of the Oakland Civil Liberties Alliance (OCLA).
Dr. Gieringer has published research on medical marijuana usage, marijuana smoke harm reduction, potency testing, marijuana and driving safety, and drug urinalysis. He has testified before the legislature and in court on issues concerning personal use of marijuana. He was one of the original co-authors of California’s medical marijuana initiative, Prop. 215, and the proponent of Oakland’s Measure Z cannabis initiative in 2004.
Books: Marijuana Medical Handbook (co-authors: Ed Rosenthal and Dr. Greg Carter) Quick Publications, Second edition 2008.
California NORML Guide to Drug Testing (Regent Press, 2013).
Editor: California NORML Reports, 1987- present.Editorial Board: Journal of Cannabis Therapeutics (2001-2005)
California Center for Medicinal Cannabis Research, UC San Diego
Americans for Safe Access Legal Advisory Committee
CHP Impaired Driving Task Force – 2018 to present
City of Oakland Measure Z Cannabis Oversight Commission, 2006-2017 (Vice Chairman 2008).
“Practical experience with legalized cannabis,” Addiction 107 #5: 875-6. May 2012.
“How Accurate is Potency Testing?” O-Shaughnessy’s, Autumn 2011.
“The Marihuana Tax Act of 1937” in Encyclopedia of Drug Policy, (Ed. Kleiman and Hawdon, 2011)
“State’s war on drugs a 100-year-old bust,” Insight section, San Francisco Chronicle, March 4, 2007.
“Advice for Medical Marijuana Providers,” in Richard Glen Boire & Kevin Feeney, ed., Medical Marijuana Law (Ronin Press, 2006)
“Roadside sobriety tests and attitudes toward a regulated cannabis market” co-author with Alison Looby & Mitch Earleywine, Harm Reduction Journal 4:4 (31 Jan 2007)
“Jack London, California’s Cannabis Pioneer” Oaksterdam News (Spring 2005)
“Cannabis Vaporizer Combines Efficient Delivery of THC With Effective Suppression Of Pyrolytic Compounds” Journal of Cannabis Therapeutics Vol. 4 #1 (2004).
“Ronald Reagan: An Autopsy,” Liberty, August 2004.
“The Acceptance of Medicinal Marijuana in the U.S.” Journal of Cannabis Therapeutics Vol. 3 #1 (2003) pp. 53-67.
“Cannabis Vaporization: A Promising Strategy for Smoke Harm Reduction,” Journal of Cannabis Therapeutics, Vol. 1 #3/4: 153-70 (2001).
“The 125th Anniversary of the War on Drugs,” Liberty, January 2001
“Medical Uses of Cannabis: Experience in California,” in Grotenhermen, F., Russo, E., ed. Cannabis and Cannabinoids – Pharmacology, Toxicology and Therapeutic Potential, Haworth, New York (2002)
“The Forgotten Origins of Cannabis Prohibition in California,” Contemporary Drug Problems, Summer 1999 Vol. 26:237-88
“The Economics of Cannabis Legalization” in Ed Rosenthal, ed. Hemp Today (Quick Publishing, 1994).
“Marijuana Health Mythology,” California NORML 1994
“Urinalysis or Uromancy?,” in Trebach & Zeese, ed. Strategies for Change: New Directions in Drug Policy (Drug Policy Foundation 1992)
“Health Tips for Marijuana Smokers,” California NORML 1992
“The Health Hazards of Marijuana,” Sinsemilla Tips (Spring 1990)
“How Many Crack Babies?” in Trebach & Zeese, ed. Drug Prohibition and the Conscience of Nations (Drug Policy Foundation, 1990)
“Towards a Users’ Rights Drug Policy,” in Trebach & Zeese, ed. Drug Policy 1989-1990 (Drug Policy Foundation, 1989)
“Marijuana, Driving and Accident Safety,” Journal of Psychoactive Drugs, 20#1: 93-101 (Jan-Mar 1988).
“The DEA” Reason, December 1986.
“Compassion Vs. Control: FDA Investigational-Drug Regulation,” Cato Policy Analysis #72, May 1986.
“The FDA’s Bad Medicine,” Policy Review #33 (Summer 1985).
“The Safety and Efficacy of New Drug Approval,” Cato Journal 5#1:177-201 (Spring/Summer 1985).
Laboratory Ring Test with Project CBD
Medical Cannabis Vaporizer Project
Medical Cannabis Potency Testing Project, (MAPS Newsletter, IX#, 1999, pp.20-2)
Marijuana Waterpipe/Vaporizer Study (MAPS Newsletter, VI#3, 1996, pp. 59-66)
Ph.D., Stanford University Dept of Engineering-Economic Systems (1984). Thesis: “Consumer Choice and FDA Drug Regulation.”